As of 2026-04-03, the EV/EBITDA ratio of NGM Biopharmaceuticals Inc (NGM) is -0.49. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. NGM's latest enterprise value is 72.71 mil USD. NGM's TTM EBITDA according to its financial statements is -149.48 mil USD. Dividing these 2 quantities gives us the above NGM EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 5.6x - 6.8x | 6.2x |
| Forward P/E multiples | 6.3x - 9.3x | 7.8x |
| Fair Price | (10.65) - (11.58) | (11.87) |
| Upside | -791.6% - -852.1% | -870.7% |
| Date | EV/EBITDA |